Mallinckrodt most likely has already seen Phase 1 results, and now has the drugs and facilities for Oncolix to continue Phase 2 or rollover Phase 3 to continue and be effective. Oncolix with only 5% of the market on this drug is worth over $1 Billion...so Mallinckrodt took stake for trade on drugs/facility.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.